Robert S. Klein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert S. Klein has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ellie E. Schoenbaum
Albert Einstein College of Medicine, Bronx, NY
2 shared publications - Marc. N. Gourevitch
Department of Population Health, New York University School of Medicine, New York, New York
2 shared publications R Teeter
2 shared publicationsAdrian S. Dobs
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
1 shared publicationCheryl Smith
Department of Medicine, North General Hospital, New York, New York
1 shared publicationJoseph P. McGowan
Division of Infectious Diseases, Bronx
1 shared publication
Latest Publications
- Open Access
- 12 August 2008
- Published by Wiley in HIV Medicine
- Vol. 9 (7) , 544-549
Abnormal thyroid function in older men with or at risk for HIV infection*
Objectives The aim of the study was to evaluate the prevalence of and factors associated with abnormal thyroid function in older men with or at risk for HIV infection. Methods A cross‐sectional analysis of 636 men ≥49 years old was carried out using data obtained from interviews, from measurements of body mass index (BMI), HIV‐1 serology and viral load, CD4 cell count, hepatitis C virus (HCV) assays, thyroid‐stimulating hormone (TSH) and free thyroid hormone levels. Results Participants were 54% black, 57% overweight/obese, 57% HIV seropositive, and 72% HCV seropositive; 38% reported recent cocaine or heroin use. Decreased TSH was found in 56 men (8.8%) and raised TSH in 23 men (3.6%). Only three men had abnormal free thyroxine levels. Conclusions Abnormal TSH levels were noted in 12.4% of older men with or at risk for HIV infection, but nearly all reflected subclinical hyperthyroidism or subclinical hypothyroidism.
- 12 August 2008
- Published by Wiley in HIV Medicine
- Vol. 9 (7) , 544-549
Open AccessAbnormal thyroid function in older men with or at risk for HIV infection*
Objectives The aim of the study was to evaluate the prevalence of and factors associated with abnormal thyroid function in older men with or at risk for HIV infection. Methods A cross‐sectional analysis of 636 men ≥49 years old was carried out using data obtained from interviews, from measurements of body mass index (BMI), HIV‐1 serology and viral load, CD4 cell count, hepatitis C virus (HCV) assays, thyroid‐stimulating hormone (TSH) and free thyroid hormone levels. Results Participants were 54% black, 57% overweight/obese, 57% HIV seropositive, and 72% HCV seropositive; 38% reported recent cocaine or heroin use. Decreased TSH was found in 56 men (8.8%) and raised TSH in 23 men (3.6%). Only three men had abnormal free thyroxine levels. Conclusions Abnormal TSH levels were noted in 12.4% of older men with or at risk for HIV infection, but nearly all reflected subclinical hyperthyroidism or subclinical hypothyroidism.
- Open Access
- 15 December 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (12) , 1794-1803
Androgen Levels in Older Men Who Have or Who Are at Risk of Acquiring HIV Infection
Objective. To determine the prevalence of, risk factors for, and clinical manifestations of low androgen levels in older men who have or who are at risk of acqu
- 15 December 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (12) , 1794-1803
Open AccessAndrogen Levels in Older Men Who Have or Who Are at Risk of Acquiring HIV Infection
Objective. To determine the prevalence of, risk factors for, and clinical manifestations of low androgen levels in older men who have or who are at risk of acqu
- Open Access
- 15 November 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (10) , 1551
Chronic Liver Disease and Streptococcus bovis Endocarditis
SIR—The interesting report by Tripodi and colleagues [1] confirms prior reports of Streptococcus bovis endocarditis being associated with advanced age and involvement of native valves. However, the authors comment that their most interesting finding was a remarkable association with chronic liver disease. Caution appears warranted in concluding that there is such an association. Liver disease was due to viral hepatitis in most patients with S. bovis endocarditis and in all patients with other types of endocarditis. Chronic liver disease due to hepatitis B virus or hepatitis C virus typically develops over decades, so that the rates of liver disease would be expected to be higher among older individuals with these infections. Patients with S. bovis endocarditis were significantly older than those with non–S. bovis endocarditis, with a mean age difference of more than a decade. Although all patients underwent serological testing for hepatitis C and hepatitis B markers, results were not provided for patients without chronic liver disease, so the reader cannot determine whether viral hepatitis infection rates differed overall according to the microbial etiology of endocarditis.
- 15 November 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (10) , 1551
Open AccessChronic Liver Disease and Streptococcus bovis Endocarditis
SIR—The interesting report by Tripodi and colleagues [1] confirms prior reports of Streptococcus bovis endocarditis being associated with advanced age and involvement of native valves. However, the authors comment that their most interesting finding was a remarkable association with chronic liver disease. Caution appears warranted in concluding that there is such an association. Liver disease was due to viral hepatitis in most patients with S. bovis endocarditis and in all patients with other types of endocarditis. Chronic liver disease due to hepatitis B virus or hepatitis C virus typically develops over decades, so that the rates of liver disease would be expected to be higher among older individuals with these infections. Patients with S. bovis endocarditis were significantly older than those with non–S. bovis endocarditis, with a mean age difference of more than a decade. Although all patients underwent serological testing for hepatitis C and hepatitis B markers, results were not provided for patients without chronic liver disease, so the reader cannot determine whether viral hepatitis infection rates differed overall according to the microbial etiology of endocarditis.
- Open Access
- 15 November 2002
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (10) , 1238-1243
Comorbid Conditions, Treatment, and Health Maintenance in Older Persons with Human Immunodeficiency Virus Infection in New York City
We retrospectively examined comorbid conditions and health maintenance in 198 patients aged ⩾55 years who attended 3 New York City human immunodeficiency virus (HIV) clinics between 1 January 1990 and 30 June 1998. Annual influenza and pneumococcal vaccinations within 5 years were given in 82% and 86% of patients, respectively. Among 57 women, 79% had a Papanicolaou smear within 1 year, and 53% had a mammogram within 2 years. Of 165 patients who received care after 1 July 1996, 147 (89%) had comorbid conditions (mean number of conditions, 2.4), and 133 (81%) received HIV-unrelated medications (mean number of medications, 2.7). Receipt of highly active antiretroviral therapy, its discontinuation because of toxicity, and having an undetectable HIV load were not related to comorbid conditions or use of concurrent medications. Comorbid conditions and use of concurrent HIV-unrelated medications need not adversely affect treatment of HIV-infected older individuals, but increased attention to health maintenance may be necessary.
- 15 November 2002
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (10) , 1238-1243
Open AccessComorbid Conditions, Treatment, and Health Maintenance in Older Persons with Human Immunodeficiency Virus Infection in New York City
We retrospectively examined comorbid conditions and health maintenance in 198 patients aged ⩾55 years who attended 3 New York City human immunodeficiency virus (HIV) clinics between 1 January 1990 and 30 June 1998. Annual influenza and pneumococcal vaccinations within 5 years were given in 82% and 86% of patients, respectively. Among 57 women, 79% had a Papanicolaou smear within 1 year, and 53% had a mammogram within 2 years. Of 165 patients who received care after 1 July 1996, 147 (89%) had comorbid conditions (mean number of conditions, 2.4), and 133 (81%) received HIV-unrelated medications (mean number of medications, 2.7). Receipt of highly active antiretroviral therapy, its discontinuation because of toxicity, and having an undetectable HIV load were not related to comorbid conditions or use of concurrent medications. Comorbid conditions and use of concurrent HIV-unrelated medications need not adversely affect treatment of HIV-infected older individuals, but increased attention to health maintenance may be necessary.
- 1 August 2001
- Vol. 5 (8) , 707-11
The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
In persons infected with the human immunodeficiency virus (HIV), a decreased tuberculin reaction cut-point of > or = 5 mm induration is recommended. To determine tuberculosis risk in non-anergic HIV-infected persons with 5-9 mm tuberculin reactions. A prospective study with semi-annual tuberculin and anergy testing, HIV antibody and T cell subset assays, and active surveillance for tuberculosis. Participants were 572 HIV-seronegative and 241 HIV-seropositive non-anergic drug users. No tuberculosis occurred in HIV-seronegative persons. Tuberculosis incidence among HIV-seropositive drug users was 3.3, 7.7, 0, and 0.34 per 100 person-years in those with tuberculin reaction sizes of > or = 10 mm, 5-9 mm, 1-4 mm, and 0 mm, respectively, and was significantly increased in persons with 5-9 mm induration compared with those with 0-4 mm induration (rate ratio 27.7, 95%CI 2.9-268). Among persons with reaction sizes of 5-9 mm, tuberculosis occurred exclusively in those with CD4+ lymphocyte counts <500/mm3 at the time of their 5-9 mm tuberculin reactions. HIV-infected persons with tuberculin reaction sizes of 5-9 mm are at increased risk for tuberculosis compared to non-anergic persons with smaller (0-4 mm) reaction sizes. However, this increased risk may be limited to those with low CD4+ lymphocyte counts at the time of tuberculin testing.
- 1 August 2001
- Vol. 5 (8) , 707-11
The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
In persons infected with the human immunodeficiency virus (HIV), a decreased tuberculin reaction cut-point of > or = 5 mm induration is recommended. To determine tuberculosis risk in non-anergic HIV-infected persons with 5-9 mm tuberculin reactions. A prospective study with semi-annual tuberculin and anergy testing, HIV antibody and T cell subset assays, and active surveillance for tuberculosis. Participants were 572 HIV-seronegative and 241 HIV-seropositive non-anergic drug users. No tuberculosis occurred in HIV-seronegative persons. Tuberculosis incidence among HIV-seropositive drug users was 3.3, 7.7, 0, and 0.34 per 100 person-years in those with tuberculin reaction sizes of > or = 10 mm, 5-9 mm, 1-4 mm, and 0 mm, respectively, and was significantly increased in persons with 5-9 mm induration compared with those with 0-4 mm induration (rate ratio 27.7, 95%CI 2.9-268). Among persons with reaction sizes of 5-9 mm, tuberculosis occurred exclusively in those with CD4+ lymphocyte counts <500/mm3 at the time of their 5-9 mm tuberculin reactions. HIV-infected persons with tuberculin reaction sizes of 5-9 mm are at increased risk for tuberculosis compared to non-anergic persons with smaller (0-4 mm) reaction sizes. However, this increased risk may be limited to those with low CD4+ lymphocyte counts at the time of tuberculin testing.
- 1 December 1999
- Published by Springer Nature in Journal of Urban Health
- Vol. 76 (4) , 435-447
Self-reported legal needs of women with or at risk for HIV infection
Women at risk for human immunodeficiency virus (HIV) infection are often poor and members of racial or ethnic minorities. In addition to legal concerns that might be common among persons with similar sociodemographic characteristics, HIV infection adds the potential of possible stigma and discrimination, as well as the prospect of illness and increased mortality. To determine women's perceptions of need for and access to legal services and whether such perceptions are affected by HIV infection, from November 1993 through September 1995 we interviewed 509 women with or at risk for HIV infection by virtue of injection drug use or high-risk sexual behaviors in New York and Baltimore, Maryland. A majority of women, regardless of HIV serostatus, reported current or future needs for legal assistance with government benefits. More than 25% reported needing current or future legal help with housing, debts, arrangements for care of children, a will, and advance directives. Substantial minorities of women reported other legal needs. HIV-positive women were significantly more likely to report anticipated future need for help with paternal custody or visitation, current need in making a will, and anticipated future assistance with advance directives. For most items, a majority of women thought they knew where to receive help. However, among women reporting a current need, only a minority actually were receiving legal assistance. This study suggests that the extent of legal needs among women with or at risk for HIV infection is substantial, and that few receive legal assistance. With few exceptions, at least for women early in the course of illness, HIV infection does not appear to alter the pattern or extent of legal needs. There are dramatic differences, regardless of HIV status, between expectation and reality in women's access to legal services.
- 1 December 1999
- Published by Springer Nature in Journal of Urban Health
- Vol. 76 (4) , 435-447
Self-reported legal needs of women with or at risk for HIV infection
Women at risk for human immunodeficiency virus (HIV) infection are often poor and members of racial or ethnic minorities. In addition to legal concerns that might be common among persons with similar sociodemographic characteristics, HIV infection adds the potential of possible stigma and discrimination, as well as the prospect of illness and increased mortality. To determine women's perceptions of need for and access to legal services and whether such perceptions are affected by HIV infection, from November 1993 through September 1995 we interviewed 509 women with or at risk for HIV infection by virtue of injection drug use or high-risk sexual behaviors in New York and Baltimore, Maryland. A majority of women, regardless of HIV serostatus, reported current or future needs for legal assistance with government benefits. More than 25% reported needing current or future legal help with housing, debts, arrangements for care of children, a will, and advance directives. Substantial minorities of women reported other legal needs. HIV-positive women were significantly more likely to report anticipated future need for help with paternal custody or visitation, current need in making a will, and anticipated future assistance with advance directives. For most items, a majority of women thought they knew where to receive help. However, among women reporting a current need, only a minority actually were receiving legal assistance. This study suggests that the extent of legal needs among women with or at risk for HIV infection is substantial, and that few receive legal assistance. With few exceptions, at least for women early in the course of illness, HIV infection does not appear to alter the pattern or extent of legal needs. There are dramatic differences, regardless of HIV status, between expectation and reality in women's access to legal services.
- 1 April 1999
- Vol. 3 (4) , 321-5
Self-assessment of tuberculin skin test reactions by drug users with or at risk for human immunodeficiency virus infection.
Self-assessment of tuberculin test results, if accurate, could enhance tuberculosis screening efforts by reducing the need for follow-up visits for skin test reading. We investigated tuberculin test self-assessment in a longitudinal study of tuberculosis infection among drug users. To determine the accuracy of tuberculin reaction self-assessment by drug users at high risk for tuberculosis infection. Two readings were compared of the same skin test, performed 48-72 hours after placement: 1) self-assessment using a simple yes-no approach to induration, versus 2) trained examiner reading. Self-assessments were performed immediately prior to trained examiner readings. Participants were 137 human immunodeficiency virus (HIV) seropositive and 344 HIV-seronegative current and former drug users. Ten per cent (35/344) of reactions read by participants as 'flat' were read by trained examiners as > or =5 mm (54% of which were > or =10 mm). Twenty-three per cent (19/82) of reactions read by trained examiners as > or =10 mm and 32% (35/110) of reactions read by trained examiners as being > or =5 mm were self-read by participants as 'flat'. Sensitivity (0.68) and specificity (0.83) of self-read tuberculin reactions were sub-optimal. Inter-reader reliability was poorer between participants and trained examiners than between trained examiners. Self-assessments of tuberculin skin test responses by drug users with or at risk for HIV infection are not reliable.
- 1 April 1999
- Vol. 3 (4) , 321-5
Self-assessment of tuberculin skin test reactions by drug users with or at risk for human immunodeficiency virus infection.
Self-assessment of tuberculin test results, if accurate, could enhance tuberculosis screening efforts by reducing the need for follow-up visits for skin test reading. We investigated tuberculin test self-assessment in a longitudinal study of tuberculosis infection among drug users. To determine the accuracy of tuberculin reaction self-assessment by drug users at high risk for tuberculosis infection. Two readings were compared of the same skin test, performed 48-72 hours after placement: 1) self-assessment using a simple yes-no approach to induration, versus 2) trained examiner reading. Self-assessments were performed immediately prior to trained examiner readings. Participants were 137 human immunodeficiency virus (HIV) seropositive and 344 HIV-seronegative current and former drug users. Ten per cent (35/344) of reactions read by participants as 'flat' were read by trained examiners as > or =5 mm (54% of which were > or =10 mm). Twenty-three per cent (19/82) of reactions read by trained examiners as > or =10 mm and 32% (35/110) of reactions read by trained examiners as being > or =5 mm were self-read by participants as 'flat'. Sensitivity (0.68) and specificity (0.83) of self-read tuberculin reactions were sub-optimal. Inter-reader reliability was poorer between participants and trained examiners than between trained examiners. Self-assessments of tuberculin skin test responses by drug users with or at risk for HIV infection are not reliable.